Drug Trial Radar · NCT00687713
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
Last checked: Nov 19, 2026Latest source record: Mar 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
May 2008
Primary completion
May 2011
Study completion May 2011
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- First posted
- Jun 2, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is to assess the efficacy of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence who report using methamphetamine 29 or less days during the 30 days prior to the start of signing consent.
Conditions
- Methamphetamine Dependence
Interventions
BupropionDrug
150mg for the first 3 days of dosing. Increased to 150 mg b.i.d until taper.
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Showing AbstinenceTime frame: Weeks 11 and 12
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
UCLA Integrated Substance Abuse Program
Los Angeles, California
South Bay Treatment Center
San Diego, California
Addiction and Pharmacology Research Laboratory
San Francisco, California
Friends Research Institute
Torrance, California
Matrix Institute
Woodland Hills, California
Pacific Addiction Research Center - U of Hawaii
Honolulu, Hawaii
Iowa Luther Hospital
Des Moines, Iowa
U of Kansas Medical Center
Kansas City, Missouri
New York University
New York, New York
Medical University of South Carolina
Charleston, South Carolina
University of Texas Health Science At San Antonio
San Antonio, Texas
VA Salt Lake City Health Care System
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.